Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties1

By A. Moschen, A. Kaser, Barbara Enrich, B. Mosheimer, M. Theurl, H. Niederegger, Herbert Tilg. Journal of Immunology, 2007

599 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Biochemistry of adipose tissue: an endocrine organ (2013, background): “Moreover, IL-6 can promote fatty acid oxidation and glucose uptake in skeletal muscle findings, which are also observed with the IL-6 family member ciliary neurotrophic factor (CNTF) [32, 33].”
Oxidative Stress in Obesity: A Critical Component in Human Diseases (2014, background): “In experimental research, Moschen and colleagues demonstrated that visfatin, whose serum levels are higher in patients with inflammatory disease, including obesity, than in healthy subjects [41], induced human leukocytes and pro- and anti-inflammatory cytokine production (IL-1b, IL-1Ra, IL-6, IL-8, ”
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (2007, background): “Additionally, because this protein lacks a signal sequence for secretion, it has been suggested that the presence of Nampt/PBEF/visfatin in extracellular compartments might be simply due to either cell lysis or cell death (Hug and Lodish, 2005; Stephens and Vidal-Puig, 2006).”
Adipokines: the missing link between insulin resistance and obesity. (2008, background): “[87] Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niedderegger H, et al.”
Obesity in autoimmune diseases: not a passive bystander. (2014, unknown): “[176–180,183–186]”